Emblation was established on the belief that the future of medical technology will be defined by the significant growth in investment, research, and product development in immune-modulating treatments (IM®) – a unifying concept that has driven our company structure, investment in technology, skills, partnerships, and clinical research.

Holyrood PR’s team of tech PR experts helps Emblation on their journey to creating more accessible, reliable and compact medical microwave systems and to develop therapies that could be used in dermatology and podiatry that would overcome the shortfalls in traditional treatments for skin lesions.